SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Haefaa Alchalby, Tatjana Zabelina, Thomas Stübig, Anja van Biezen, Martin Bornhäuser, Paolo Di Bartolomeo, Dietrich Beelen, Jean Yves Cahn, Peter Dreger, William Schroyens, Theo de Witte, Eduardo Olavarria, Nicolaus Kröger, Allogeneic Stem Cell Transplantation for Myelofibrosis with Leukemic Transformation: A Study from the Myeloproliferative Neoplasm Subcommittee of the CMWP of the European Group for Blood and Marrow Transplantation, Biology of Blood and Marrow Transplantation, 2014, 20, 2, 279

    CrossRef

  2. 2
    Rongfeng Fu, Min Xuan, Cuicui Lv, Liyan Zhang, Huiyuan Li, Xian Zhang, Donglei Zhang, Tiantian Sun, Feng Xue, Xiaofan Liu, Haoyue Liang, Lei Zhang, Renchi Yang, External validation and clinical evaluation of the International Prognostic Score of Thrombosis for Essential Thrombocythemia (IPSET-thrombosis) in a large cohort of Chinese patients, European Journal of Haematology, 2014, 92, 6
  3. 3
    Helna Pettersson, Håvar Knutsen, Erik Holmberg, Björn Andréasson, Increased incidence of another cancer in myeloproliferative neoplasms patients at the time of diagnosis, European Journal of Haematology, 2014, 93, 4
  4. 4
    Raajit Rampal, John Mascarenhas, Pathogenesis and management of acute myeloid leukemia that has evolved from a myeloproliferative neoplasm, Current Opinion in Hematology, 2014, 21, 2, 65

    CrossRef

  5. 5
    Mark L. Heaney, Gabriela Soriano, Acute Myeloid Leukemia Following a Myeloproliferative Neoplasm: Clinical Characteristics, Genetic Features and Effects of Therapy, Current Hematologic Malignancy Reports, 2013, 8, 2, 116

    CrossRef

  6. 6
    Jelena D. Milosevic, Robert Kralovics, Genetic and epigenetic alterations of myeloproliferative disorders, International Journal of Hematology, 2013, 97, 2, 183

    CrossRef

  7. 7
    Johanna Abelsson, Björn Andréasson, Jan Samuelsson, Malin Hultcrantz, Elisabeth Ejerblad, Berit Johansson, Robyn Emanuel, Ruben Mesa, Peter Johansson, Patients with polycythemia vera have worst impairment of quality of life among patients with newly diagnosed myeloproliferative neoplasms, Leukemia & Lymphoma, 2013, 54, 10, 2226

    CrossRef

  8. 8
    Peter Johansson, Ruben Mesa, Robyn Scherber, Johanna Abelsson, Jan Samuelsson, Gunnar Birgegård, Björn Andréasson, Association between quality of life and clinical parameters in patients with myeloproliferative neoplasms, Leukemia & Lymphoma, 2012, 53, 3, 441

    CrossRef

  9. You have free access to this content9
    Jelena D. Milosevic, Ana Puda, Luca Malcovati, Tiina Berg, Michael Hofbauer, Alexey Stukalov, Thorsten Klampfl, Ashot S. Harutyunyan, Heinz Gisslinger, Bettina Gisslinger, Tatiana Burjanivova, Elisa Rumi, Daniela Pietra, Chiara Elena, Alessandro M. Vannucchi, Michael Doubek, Dana Dvorakova, Blanka Robesova, Rotraud Wieser, Elisabeth Koller, Nada Suvajdzic, Dragica Tomin, Natasa Tosic, Jacques Colinge, Zdenek Racil, Michael Steurer, Sonja Pavlovic, Mario Cazzola, Robert Kralovics, Clinical significance of genetic aberrations in secondary acute myeloid leukemia, American Journal of Hematology, 2012, 87, 11
  10. 10
    Ana Puda, Jelena D. Milosevic, Tiina Berg, Thorsten Klampfl, Ashot S. Harutyunyan, Bettina Gisslinger, Elisa Rumi, Daniela Pietra, Luca Malcovati, Chiara Elena, Michael Doubek, Michael Steurer, Natasa Tosic, Sonja Pavlovic, Paola Guglielmelli, Lisa Pieri, Alessandro M. Vannucchi, Heinz Gisslinger, Mario Cazzola, Robert Kralovics, Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies, American Journal of Hematology, 2012, 87, 3
  11. 11
    T. Klampfl, A. Harutyunyan, T. Berg, B. Gisslinger, M. Schalling, K. Bagienski, D. Olcaydu, F. Passamonti, E. Rumi, D. Pietra, R. Jager, L. Pieri, P. Guglielmelli, I. Iacobucci, G. Martinelli, M. Cazzola, A. M. Vannucchi, H. Gisslinger, R. Kralovics, Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression, Blood, 2011, 118, 1, 167

    CrossRef

  12. 12
    Jerry L Spivak, Hans Hasselbalch, Hydroxycarbamide: a user’s guide for chronic myeloproliferative disorders, Expert Review of Anticancer Therapy, 2011, 11, 3, 403

    CrossRef

  13. 13
    Carolyn M. Butcher, Petra J. Neufing, Lena Eriksson, Catherine L. Carmichael, Ella J. Wilkins, Junia V. Melo, Ian D. Lewis, Peter G. Bardy, Hamish S. Scott, Richard J. D’Andrea, RUNX1 mutations are rare in chronic phase polycythaemia vera, British Journal of Haematology, 2011, 153, 5
  14. 14
    Khadija Abdulkarim, Börje Ridell, Peter Johansson, Jack Kutti, Soodabeh Safai-Kutti, Björn Andréasson, The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera, European Journal of Haematology, 2011, 86, 2
  15. 15
    Francesco Passamonti, Elisa Rumi, Luca Arcaini, Chiara Elena, Carlo Castagnola, Patrizia Zappasodi, Paolo Bernasconi, Daniela Pietra, Cristiana Pascutto, Mario Cazzola, Mario Lazzarino, Blast phase of essential thrombocythemia: A single center study, American Journal of Hematology, 2009, 84, 10